Baig AM, Khaleeq A, Ali U, Syeda H Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
Balmer JE, Blomhoff R Gene expression regulation by retinoic acid. J Lipid Res. 2002 Nov;43(11):1773-808. Review.
Barnes PJ Theophylline. Pharmaceuticals (Basel). 2010 Mar 18;3(3):725-747. Review.
Blomqvist EH, Lundblad L, Bergstedt H, Stjärne P Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol. 2003 Sep;123(7):862-8.
Brann JH, Firestein SJ A lifetime of neurogenesis in the olfactory system. Front Neurosci. 2014 Jun 26;8:182. doi: 10.3389/fnins.2014.00182. eCollection 2014. Review.
Budha NR, Ji T, Musib L, Eppler S, Dresser M, Chen Y, Jin JY Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation. Clin Pharmacokinet. 2016 Nov;55(11):1435-1445.
Calder PC Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017 Oct 15;45(5):1105-1115. doi: 10.1042/BST20160474. Epub 2017 Sep 12. Review.
Doty RL, Shaman P, Kimmelman CP, Dann MS University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984 Feb;94(2 Pt 1):176-8.
Dunlop BW, Gray J, Rapaport MH Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings. Behav Sci (Basel). 2017 Jun 27;7(3). pii: E40. doi: 10.3390/bs7030040.
Friedman M, Hamilton C, Samuelson CG, Maley A, Wilson MN, Venkatesan TK, Joseph NJ Dead Sea salt irrigations vs saline irrigations with nasal steroids for symptomatic treatment of chronic rhinosinusitis: a randomized, prospective double-blind study. Int Forum Allergy Rhinol. 2012 May-Jun;2(3):252-7. doi: 10.1002/alr.21003. Epub 2012 Feb 15.
Gebara MA, Lipsey KL, Karp JF, Nash MC, Iaboni A, Lenze EJ Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review. Am J Geriatr Psychiatry. 2015 Oct;23(10):1016-28. doi: 10.1016/j.jagp.2014.11.004. Epub 2014 Nov 25. Review.
Gopinath B, Sue CM, Flood VM, Burlutsky G, Mitchell P Dietary intakes of fats, fish and nuts and olfactory impairment in older adults. Br J Nutr. 2015 Jul;114(2):240-7. doi: 10.1017/S0007114515001257. Epub 2015 Jun 16.
Graziadei PP, Levine RR, Monti Graziadei GA Plasticity of connections of the olfactory sensory neuron: regeneration into the forebrain following bulbectomy in the neonatal mouse. Neuroscience. 1979;4(6):713-27.
Hallifax D, Houston JB Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. Drug Metab Dispos. 2007 Aug;35(8):1325-32. Epub 2007 Apr 30.
Hashimoto K Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. J Pharmacol Sci. 2015 Jan;127(1):6-9. doi: 10.1016/j.jphs.2014.11.010. Epub 2014 Dec 4. Review.
Hashimoto K Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol. 2013 Jan;100:15-29. doi: 10.1016/j.pneurobio.2012.09.001. Epub 2012 Oct 5. Review.
Hendriks AP Olfactory dysfunction. Rhinology. 1988 Dec;26(4):229-51. Review.
Henkin RI, Schultz M, Minnick-Poppe L Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1064-70. doi: 10.1001/2013.jamaoto.342.
Henkin RI, Velicu I, Schmidt L An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009 Jun;337(6):396-406. doi: 10.1097/MAJ.0b013e3181914a97.
Henkin RI, Velicu I cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction. Clin Invest Med. 2008;31(2):E78-84.
Henkin RI, Velicu I cAMP and cGMP in nasal mucus: relationships to taste and smell dysfunction, gender and age. Clin Invest Med. 2008;31(2):E71-7.
Henry JA Overdose and safety with fluvoxamine. Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:41-5; discussion 45-7.
Hoffman HJ, Rawal S, Li CM, Duffy VB New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016 Jun;17(2):221-40. doi: 10.1007/s11154-016-9364-1. Review.
Hummel T, Whitcroft KL, Rueter G, Haehner A Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2819-2825. doi: 10.1007/s00405-017-4576-x. Epub 2017 Apr 22.
Ishima T, Fujita Y, Hashimoto K Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Eur J Pharmacol. 2014 Mar 15;727:167-73. doi: 10.1016/j.ejphar.2014.01.064. Epub 2014 Feb 5.
Lechien JR, Barillari MR, Jouffe L, Saussez S Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool. Ear Nose Throat J. 2020 Nov;99(9):577-578. doi: 10.1177/0145561320925191. Epub 2020 May 21.
Lenze EJ, Stevens A, Waring JD, Pham VT, Haddad R, Shimony J, Miller JP, Bowie CR Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial. Am J Psychiatry. 2020 Jun 1;177(6):548-555. doi: 10.1176/appi.ajp.2019.19050561. Epub 2020 Mar 26. Erratum in: Am J Psychiatry. 2020 Jun 1;177(6):556.
Levy LM, Henkin RI, Lin CS, Hutter A, Schellinger D Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comput Assist Tomogr. 1998 Sep-Oct;22(5):760-70.
Lewis R, Li J, McCormick PJ, L-H Huang C, Jeevaratnam K Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review. Int J Cardiol Heart Vasc. 2019 Dec 28;26:100449. doi: 10.1016/j.ijcha.2019.100449. eCollection 2020 Feb. Review. Erratum in: Int J Cardiol Heart Vasc. 2020 Dec 19;32:100700.
Meng X, Deng Y, Dai Z, Meng Z COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020 Sep - Oct;41(5):102581. doi: 10.1016/j.amjoto.2020.102581. Epub 2020 Jun 2. Review.
Morbini P, Benazzo M, Verga L, Pagella FG, Mojoli F, Bruno R, Marena C Ultrastructural Evidence of Direct Viral Damage to the Olfactory Complex in Patients Testing Positive for SARS-CoV-2. JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):972-973. doi: 10.1001/jamaoto.2020.2366.
Nguyen TP, Patel ZM Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int Forum Allergy Rhinol. 2018 Sep;8(9):977-981. doi: 10.1002/alr.22140. Epub 2018 Jun 14.
Nishimura T, Ishima T, Iyo M, Hashimoto K Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One. 2008 Jul 2;3(7):e2558. doi: 10.1371/journal.pone.0002558.
Pekala K, Chandra RK, Turner JH Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016 Mar;6(3):299-307. doi: 10.1002/alr.21669. Epub 2015 Dec 1. Review.
Politi LS, Salsano E, Grimaldi M Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020 Aug 1;77(8):1028-1029. doi: 10.1001/jamaneurol.2020.2125.
Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB Prevalence and Risk Factors of Self-Reported Smell and Taste Alterations: Results from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES). Chem Senses. 2016 Jan;41(1):69-76. doi: 10.1093/chemse/bjv057. Epub 2015 Oct 20.
Rawson NE, LaMantia AS A speculative essay on retinoic acid regulation of neural stem cells in the developing and aging olfactory system. Exp Gerontol. 2007 Jan-Feb;42(1-2):46-53. Epub 2006 Jul 24. Review.
Reden J, Maroldt H, Fritz A, Zahnert T, Hummel T A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2007 Feb;264(2):139-44. Epub 2006 Sep 28.
Ronnett GV, Parfitt DJ, Hester LD, Snyder SH Odorant-sensitive adenylate cyclase: rapid, potent activation and desensitization in primary olfactory neuronal cultures. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2366-9.
Saniasiaya J, Narayanan P Parosmia post COVID-19: an unpleasant manifestation of long COVID syndrome. Postgrad Med J. 2021 Mar 31. pii: postgradmedj-2021-139855. doi: 10.1136/postgradmedj-2021-139855. [Epub ahead of print]
Schiffman SS, Warwick ZS Flavor enhancement of foods for the elderly can reverse anorexia. Neurobiol Aging. 1988 Jan-Feb;9(1):24-6.
Schwob JE Neural regeneration and the peripheral olfactory system. Anat Rec. 2002 Feb 15;269(1):33-49. Review.
Seiden AM, Duncan HJ The diagnosis of a conductive olfactory loss. Laryngoscope. 2001 Jan;111(1):9-14.
Seo BS, Lee HJ, Mo JH, Lee CH, Rhee CS, Kim JW Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 2009 Oct;135(10):1000-4. doi: 10.1001/archoto.2009.141.
Soler ZM, Patel ZM, Turner JH, Holbrook EH A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol. 2020 Jul;10(7):814-820. doi: 10.1002/alr.22578. Epub 2020 Jun 1. Review.
Sukhatme VP, Reiersen AM, Vayttaden SJ, Sukhatme VV Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19. Front Pharmacol. 2021 Apr 20;12:652688. doi: 10.3389/fphar.2021.652688. eCollection 2021.
Ware JE Jr, Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
Whitcroft KL, Hummel T Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020 Jun 23;323(24):2512-2514. doi: 10.1001/jama.2020.8391. Review.
Wilson DA, Best AR, Sullivan RM Plasticity in the olfactory system: lessons for the neurobiology of memory. Neuroscientist. 2004 Dec;10(6):513-24. Review.
Yan CH, Overdevest JB, Patel ZM Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations. Int Forum Allergy Rhinol. 2019 Feb;9(2):165-176. doi: 10.1002/alr.22240. Epub 2018 Nov 24.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.